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Abstract 
In this work, a novel label-free electrochemical immunosensor for the detection of alpha-
fetoprotein (AFP) is fabricated for early diagnosis and prognostics of liver cancer. A porous 
graphene nanoribbon (PGNR) was synthesized via chemi al reduction method and it was 
electrodeposited with gold nanoparticles (AuNPs) to obtain AuNPs/PGNR hybrid 
nanomaterial. Anti-AFP was immobilized onto AuNPs/PGNR/glassy carbon electrode and 
anti-AFP/AuNPs/PGNR/GCE was further studied to demonstrate its electrocatalytic activity 
towards AFP antigen. PGNR enhances the electroactive surface area and the electron transfer 
ability between the electrode and redox probe while t e AuNPs deposited on PGNR are used 
to immobilize biomolecules and to facilitate the elctron transport. The superior biosensing 
performance towards AFP under physiological pH condition is demonstrated by a 
corresponding decreased peak current in differential pulse voltammetry for a wide linear 
range (5-60 ng/mL) with a low detection limit of 1 ng/mL. Detection of AFP in serum 
samples by this label-free electrochemical immunosesor without fouling or significant 
interference implies that the anti-AFP/AuNPs/PGNR modified GCE has a great application 
potential for clinical diagnosis of AFP.  
Keywords: Porous graphene nanoribbons, gold nanoparticles, alpha fetoprotein, differential 
pulse voltammetry. 
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1. Introduction  
Alpha fetoprotein (AFP), an oncofetal glycoprotein produced by liver, yolksac, and 
gastrointestinal tract of humans, is considered as a well-known clinical biomarker for 
hepatocellular carcinoma (HCC) [1,2]. The concentration of AFP for a healthy body is 20 ng 
mL-1. The increase of AFP above 500 ng mL-1 in human serum is an indicator of liver tumor. 
Therefore, the concentration of AFP can be used as an early indicator for diagnosis and 
prognostics of HCC and other related diseases like yolk sac cancer, testicular cancer and 
nasopharyngeal cancer [3–5] . This necessitates the dev lopment of a reliable method for 
sensitive and selective detection of AFP. Among the various detection methods available, 
such as surface plasmon resonance, quartz crystal microbalance, electrochemical 
immunosensors, atomic absorption spectrometry, chemiluminescence assay and inductively 
coupled plasma mass spectrometry, the electrochemical immunosensor has received much 
attention as the most reliable method for detection of AFP biomarker, owing to its high 
sensitivity, specificity, rapid detection, cost efficiency, low-temperature requirements and 
compact instrumentation [6–10]. Furthermore, compared with sandwich-type immunosensor, 
label-free electrochemical immunosensors have certain advantages, for instance, they could 
be directly used to diagnose and monitor the level of biomarker and avoid interference from 
conjugated markers or other endogenous species [11–13] . 
Graphene nanoribbons (GNR), possessing excellent physical, chemical, mechanical and 
biological properties [14,15], have received tremendous scientific attention in a wide range of 
applications like gas separation, water desalinatio, energy storage, fuel cells, 
electrochemical capacitors and drug delivery [16,17]. Owing to its high aspect ratio, tunable 
electronic properties, abundant edges, and defect sit s and high electron transfer rate, it has 
been considered as a potential electrode material for the fabrication of electrodes in 
electrochemical sensors. Despite its excellent properties, pristine GNR tends to form 
irreversible agglomerates or even restack to form gaphite through strong  − 	 bonds and 
van der Waal`s interaction. This agglomeration tendency has a deleterious effect on most of 
its unique properties. . Therefore, tremendous efforts have been taken on the synthesis of 
porous graphene-based materials with unique porous str cture providing higher surface area, 
abundant mass transfer channels, tunable bandgap, high pore edge activity, gas permeability, 
good mechanical stability and biochemical sensing [18]. To date, different strategies have 
been successfully developed to prepare porous graphene such as porous graphene nano 
architectures using silver nanoparticles, activation of exfoliated graphene oxide (GO) with 
KOH, hydrothermal steam etching of GO nanosheets, controlled catalytic oxidation, laser 
irradiation and electron beam irradiation [19–23]. Electrochemical activity of PGNR is 
further improved by incorporating noble metal nanoparticles into PGNR. Among numerous 
nanoparticles, AuNPs are considered as an excellent support material due to their remarkable 
surface chemical properties [24], higher chemical st bility, excellent catalytic activity[25], 
biocompatibility [26] and other notable properties [27–30].  In this work, for the first time a 
hybrid nanomaterial comprising of porous graphene nanoribbon and AuNPs is fabricated 
through chemical reduction method. Porous graphene nanoribbon was obtained by etching 
Fe2O3NPs/GNR using hydrochloric acid. AuNPs were electrochemically deposited on PGNR 
and the obtained AuNPs/PGNR hybrid nanomaterial was applied as a novel immunosensor 
electrode to detect AFP.  
2. Materials and Methods 
2.1 Materials 
Alpha-fetoprotein antibody and antigen were purchased from Biocell Co. (Zhengzhou, 
China). Bovine serum albumin (BSA, 96–99%) and multi-walled carbon nanotubes 
(MWCNT), carbon > 95% 6 - 9 nm O.D x 5 µm L were procured from Sigma (USA). 
Phosphate buffer solution (PBS), conc. sulphuric acd (H2SO4), 88% ACS ortho phosphoric 
acid (H3PO4), iron sulphate (FeSO4), potassium permanganate (KMnO4), 30% hydrogen 
peroxide (H2O2), 35% hydrochloric acid (HCl), 98% hydrazine hydrate (NH2)2: H2O, 
chloroauric acid (HAuCl4) potassium ferrocyanide (K4Fe(CN)6) and potassium ferricyanide 
(K3Fe(CN)6)  were purchased from Merck India. All the electrolytes were prepared with 
ultrapure water (>18 M Ω cm) from a Millipore Milli-Q water purification system. 
2.2 Experimental 
2.2.1 Synthesis of porous graphene nanoribbon  
As illustrated in Figure 1, 300 mg of graphene oxide nanoribbons (GONR) (Figure S1) 
obtained by unzipping of multiwalled carbon nanotube via improved method [31] was mixed 
with      0.01 M FeSO4.7H2O stock solution in which 2.8 g of FeSO4.7H2O was dissolved in 1 
mL concentrated sulfuric acid. After sonicating for 1 h, iron hydroxide GONR mixture 
obtained by the following reaction was kept under stir ing with 10 mL hydrazine hydrate for 
12 h at 80° C in nitrogen atmosphere. 
  
 The reduced iron oxide/graphene nanoribbon (Fe2O3/GNR) nanocomposite was rinsed with 
distilled water, acetone and vacuum dried for 24 h at room temperature. Finally, porous 
structured GNR was obtained through the removal of iron particles by stirring Fe2O3/GNR 
nanocomposite with 10 mL of 15% concentrated HCl for 6 h. It was further rinsed with 
distilled water and acetone before vacuum dried at room temperature for 24 h. 
 
Figure 1. Schematic representation of the synthesis of AuNPs/PGNR. 
2.2.2 Electro deposition of AuNPs on PGNR 
The AuNPs, an immobilization platform for biomolecules, was electrochemically deposited 
on PGNR by performing amperometry at a constant potential of -0.2 V for 120 s in 0.5 M 
H2SO4 with 1 g HAuCl4 [29].  
2.3 Characterization 
The morphology and elemental compostion of the as-synthesized materials were 
characterised by high resolution scanning electron microscopy (HRSEM) (FEI Quanta FEG 
200, HRSEM) and Energy Dispersive X-Ray spectra (EDX) were recorded by JEOL JSM-
6700F microscope (Japan).The phase composition of all samples was determined by X-ray 
diffraction (XRD), PANalytical X-ray diffractometer X'Pert with a Cu Kα radiation (λ = 
1.5406 Å). The Brunauer Emmett Teller (BET) surface r a was measured by BELSORP-
mini II (BEL Japan, Inc.) using N2 as the adsorption gas. The structural properties of the 
samples was carried out using Raman spectroscopy WiTech alpha 300 CRF System excited 
at 532 nm. All Electrochemical measurements were conducted using a potentiostat/ 
galvanostat PG 302N, AUT 83909 (Metrohm, Autolab, Netherlands) with a conventional 
three-electrode system in the presence of electrolyte, PBS aqueous solution, of pH 7.4.  
2.3 Fabrication of immunosensor 
The working electrode of the electrochemical immunosensor was fabricated as follows: GCE 
polished with 0.3 mm and 0.05 mm gamma alumina particles which was rinsed and sonicated 
using distilled water, ethanol; and dried under a stream of nitrogen.  
Figure 2. Schematic representation of the AuNPs/PGNR/ CE electrochemical immunosensor 
for the detection of AFP. 
GCE was modified by coating with 7 µL suspension of GONR, GNR and PGNR dispersed 
separately in DMF (1 mg/ 2 mL) by drop casting method on the electrode surface and was 
dried at room temperature under vacuum. The stepwis assembly of the 
proposed immunosensor is illustrated in Figure 2. Firstly, AuNPs were 
deposited on PGNR modified electrode and then dried in air. Next, 6 µL of anti-AFP 
(100 µg mL-1) was cast on AuNPs/PGNR/GCE modified electrode surface and incubated 
for 1h. Subsequently, to avoid interaction between anti-AFP/AuNPs/PGNR/GCE and non-
specific adsorbed antigens, the fabricated immunosensor was incubated for 1 h in 4 µL of 
0.25% bovine serum albumin (BSA). After rinsing with PBS, the 
fabricated immunosensor was ready for measurement. The fabricated immunosensor was 
stored at 4 °C when not in use. The electrochemical signal response was recorded by 
differential pulse voltammetry (DPV) in the PBS at pH=7.4, in a potential range of                    
0.2 to 1.2 V.  
3 Results and Discussion 
3.1 Morphological studies 
The morphology and elemental composition of Fe2O3/GNR and PGNR observed by HRSEM 
are illustrated in Figure 3. Figure 3(a) clearly shows that the Fe2O3 particles with a size of 




Figure 3 HRSEM images of (a) Fe2O3/GNR (b) PGNR with their respective EDX (c & d) 
The porous structure, generated upon removal of Fe nanoparticles from Fe2O3/GNR 
was validated from the HRSEM image observed in Figure 3(b)) [32,33]. The porous 
structured PGNR not only increases the specific surface area, but also prevents agglomeration 
tendency of graphene nanoribbons. Furthermore, the corresponding energy dispersive X-ray 
EDX analysis of Fe2O3/GNR shown in Figure 3(c), exhibiting strong peaks of C, O and Fe, 
suggests the formation of a Fe2O3/GNR hybrid. Moreover, the EDX measurement of PGNR 
clearly (Figure 3(d)) evidences the effective removal of Fe particles. 
 
Figure 4 HRSEM image of (a) AuNPs/PGNR its respectiv  elemental mapping and EDX 
(b & c) 
The morphology of AuNPs/PGNR as observed in Figure 4 (a) reveals that spherical shaped 
AuNPs with a diameter of 30 to 40 nm are homogeneously decorated on the PGNR. 
Elemental quantification with mapping further illustrates the uniform deposition 
of AuNPs over PGNR surface in AuNPs/PGNR hybrid (Figure 4(b)). Moreover, EDX 
analysis of the AuNPs/PGNR hybrid confirms the presence of the Au element along with C 
in the AuNPs/PGNR hybrid (Figure 4(c)). 
3.2 XRD 
The crystal structure of GONR, Fe2O3/GNR and PGNR were studied by XRD and elucidated 
in Figure S2. The XRD pattern of GONR is illustrated in Figure S2(a) displays a diffraction 
peak at 2θ=8°, corresponding to unzipping of MWCNT. The diffraction peaks of obtained 
Fe2O3/GNR hybrid depicted in Figure S2(b) at 2θ of 33.2°, 35.6°, 40.8°, 49.5°, 54.1° and 
62.5° corresponding to (104), (110), (113), (024), (116) and (214) crystal planes, 
respectively reveals the well crystalline nature of hematite phase (JCPDS no. 97-002-2505) 
[34,35]. The diffraction peak at around 25° corresponding to (002) plane 
in PGNR, indicates a successful synthesis of PGNR (Figure S2(c)). 
3.3 Raman spectroscopy 
The information about the structural properties of m dified GONR was acquired from Raman 
spectroscopy. As shown in Figure S3, the Raman spectra of GONR, Fe2O3/GNR and 
PGNR display two prominent peaks, corresponding to D and G bands. The G band at              
1570   cm-1 represents the first order scattering of the E2g mode of sp
2 C atoms and the D 
band at 1336 cm−1 is due to the structural imperfection of the A1g mode. From the intensity of 
G band (IG) and D band (ID), the average crystallite size of the sp
2 domains in graphene based 
materials was measured by the well-known Tuinstra and Koenig (TK) relation.     
L = 4.956 II 
Where, La represents the average crystallite size of sp
2 domains and the value 4.956 was 
obtained from the equation C(λ)= -12.6+0.33 λ. λ indicates the laser wavelength, 532 nm.  
The average crystallite size of sp2 domains in GONR, Fe2O3/GNR and PGNR is calculated as 
8.26, 5.98 and 4.54 nm, respectively. Reduced average crystallite size in the case of PGNR, 
compared to Fe2O3/GNR and GONR, results in the formation of defects and disorders after 
modification of GONR [36,37]. 
Moreover, the ratio between the intensity of D and G band was effectively used 
to evaluate the degree of disorder in the given samples. ID/IG ratio of GONR was increased 
from 0.6 to 0.92 & 1.09 for Fe2O3/GNR hybrid and PGNR respectively. The increased ID/IG 
ratio reveals the increased disorder and defect density generated during the transformation 
of sp2 to sp3 configuration and additional defects introduced in each step of modification. 
3.4 Surface area analysis 
The nitrogen adsorption/desorption isotherm of the PGNR displays a typical IUPAC type-IV 
adsorption isotherm pattern with a hysteresis loop, suggests an increase in the specific surface 
area of PGNR as 132 m2 g-1 by the BET measurement, whereas the specific surface area 
of reduced graphene oxide (RGO) was only 20 m2g-1. The increased surface area 
of PGNR further confirms that the porous structure effectively prevents 
the restacking property of GNR. 
3.5 Optimization of experimental conditions 
To achieve better electrochemical performance, it is necessary to optimize the pH and 
concentration of PGNR, which influence the electron transfer and activity of AFP and anti-
AFP. However, acidic or alkaline pH value of buffer would damage the immobilized protein, 
the experiment was optimized by PBS at different pH between 5.0 and 8.0. The current 
responses obtained from CV towards different pH shown in Figure S4 (a) reveals that the 
peak current increases with increase in pH from 6 to 7.5. After reaching a maximum value at 
pH 7.5, the peak current decreased with further increase of pH, indicating the optimum pH of 
7.5 for this immunosensor. Thus, PBS at physiological pH 7.4 which is closest to 7.5 was 
used as the electrolyte for electrochemical measurement throughout this study. 
In addition, the effect of PGNR concentration on the electrochemical response of the 
immunosensor was also investigated. As shown in Figure S4(b), with an increase 
in PGNR concentration from 0.5 to 2 mg/mL, the current response increased, with further 
increase in concentration, the electroactive sites on the electrode get decreased, resulting in a 
decrease in the current response. Therefore, optimal concentration of 2 mg/mL PGNR 
solution was preferred for further experiments in this study.  
3.6 Electrochemical characterization of the immunosensor 
Cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS) depicted in 
Figure S5 and Figure S6 evidence the stepwise fabric tion of immunosensor. Maximum peak 
current observed in CV of AuNPs/PGNR/GCE (Figure S5, curve a) indicates its enhanced 
electrocatalytic property. A gradual decrease in peak current observed in anti-
AFP/AuNPs/PGNR/GCE (Figure S5, curve b), and BSA/anti-AFP/AuNPs/PGNR/GCE 
(Figure S5, curve c) indicates the successful immobilization of anti-AFP and BSA on the 
electrode. Further, a decrease in peak current observed after detection of AFP on BSA/anti-
AFP/AuNPs/PGNR/GCE demonstrates the antibody–antigen r action and successful 
fabrication of immunosensor (Figure S5, curve d). The decrease in peak current in each step 
of fabrication is due to the hindrance observed towards the transfer of electrons. 
The step wise fabrication of the immunosensor was further characterized by EIS via Nyquist 
plots (Figure S6), which was recorded from 1 to 105 Hz in a solution containing 0.1 M PBS 
(pH 7.4) of [Fe(CN)6]
3-/4-.The obtained data of all the modified electrodes wre fitted by a 
Randles equivalence circuit model, including the Warburg impedance (Zw), the charge 
transfer resistance (Rct), the double layer capacitance (Cdl) and ohmic resistance of the 
electrolyte (Rs). The EIS includes a semicircle portion and a line. The semicircle portion at 
higher frequency expresses the electron-transfer limited process, and the corresponding 
diameter is equal to the Rct. After fitting the data the Rct value of 3200 Ω (curve a) observed 
in bare GCE implies a low-charge-transfer resistance of the redox couple. PGNR/GCE, 
AuNPs/PGNR/GCE modified electrodes shows a decrease in Rct to 320 Ω and 175 Ω (curve 
b and c) respectively, indicating enhanced conductivity of both the modified electrode. 
Anti-AFP immobilized on AuNPs/PGNR/GCE, blocks the active sites of the modified 
electrode and hinders the interfacial electron transfer between the redox probe and the 
modified electrode, thereby increase the charge transfer resistance to 6600 Ω (curve c). 
Further increase in Rct to 13000 Ω observed after incubating a non-conductive bioactive 
substance BSA on anti-AFP/AuNPs/PGNR/GCE indicates th  successful immobilization of 
BSA on the electrode (curve d). Increase in the Rct to 18300 Ω observed after sensing of AFP 
on BSA/anti-AFP/AuNPs/PGNR/GCE (curve e) demonstrates the effective specific 
recognition between antibodies and antigens.  
3.7 Concentration studies 
 
 
Figure 5 DPV of the fabricated immunosensor at different concentrations of AFP from 5 to 
60 ng/mL (a) and the respective calibration curves b tween peak current and concentration of 
AFP (b). 
Under optimal conditions, the performance of the prpa ed immunosensor was examined by 
DPV. The fabricated immunosensor was implemented for the det ction of AFP antigen with 
different concentrations from 5 to 60 ng/ml. Figure 5 (a) showed the electrochemical current 
responses obtained from DPV towards the addition of AFP antigen for the concentration 
range of 5 to 60 ng/mL. 
The decrease in peak current observed with an increase in AFP concentration as shown in 
Figure 5(a), indicates the non-conducting antigen AFP bound to the antibody hinders the 
electron transfer efficiency. The corresponding calibr tion plots displayed in Figure 5(b) 
implies a good linear relationship for a concentration range of 5-60 ng.mL-1 between 
electrochemical current responses and the AFP concentration with a correlation coefficient of 
R2 =0.99 and a limit of detection of 1 ng/mL. 
 
3.8 Selectivity, stability and repeatability 
The immunosensor selectivity could be investigated with 10 ng/mL AFP in the presence 
of interfering agents, which potentially coexist with AFP in human serum. The interfering 
agents like UA, DA, AA and glucose were incubated with 10 ng/mL AFP. Negligible change 
in the current value demonstrated (Figure S7) towards the interfering substances, indicates 
the high selectivity of as fabricated immunosensor towards AFP. The repeatability of 
the immunosensor was evaluated (Figure S8), using five electrodes for the detection of AFP 
(10 ng/mL). Obtained current response elucidates the excellent repeatability of this 
immunosensor, with relative standard deviation (RSD) less than 5%. The long-term storage 
stability of immunosensor, stored in PBS (pH 7.4) at 4oC, was also determined by measuring 
the current response after 30 days. The current response measured every six days as 
demonstrated in Figure S9, implies a very little decay in the peak currents (barely 5.3%). This 
clearly shows that proposed immunosensor retains excell nt stability over a period of 30 days 
with 90.6 % current response. 
We speculate that the long-term stability and repeatability of the BSA/anti-
AFP/AuNPs/PGNR modified immunosensor could be ascribed to three reasons: (1) 
the BSA/anti-AFP/AuNPs/PGNR film has good stability, (2) the biocompatibility of the 
AuNPs/PGNR is excellent, and (3) the antibody is tightly attached to the electrode. The 
better repeatability, high selectivity and good stability confirmed that the as-
prepared immunosensor is suitable for quantitative determination of AFP in real human 
samples. The performance of the PGNR/AuNPs immunosens r was compared with other 
nanomaterial (Table 1). It can be seen, that the developed immunosensor exhibited 
comparable linear range and lower detection limit. 
Table 1. The performance comparison of the developed immunosensor with other different 
Au based AFP immunosensor 
S.No Electrode material Linear range Limit of 
detection 
Reference  
1 Au/AET/PAMAM 5–500 ng/mL 3 ng/mL [38] 
2 Au/PA 5–80 ng/ml 3.7ng/mL [39] 




15–350 ng/mL 5 ng/mL [41] 
5 PdNi/N-GNRs 0.0001–16 ng/mL 0.03 pg/mL [42] 
6 Pd nanoplates 0.01 
to 75.0 ng/mL 
4 pg/mL [43] 
7 Pd–rGO 0.01to12 ng/mL. 5 pg/mL [44] 
8 AuNPs/PGNR 5-60 ng/mL 1 ng/mL This work 
 
3.9 Real sample analysis 
The reliability and precision of the immunosensor for real sample analysis are investigated by 
standard addition method to detect the recoveries of different concentrations of AFP in the 
human serum sample. The results obtained are tabulaed in Table 2. The recovery of the 
spiked sample ranging between 99.9% and 102 %, validates the applicability of the proposed 
immunosensor for real sample analysis. 
Table 2 Determination of AFP added in human blood serum with the proposed 
immunosensor. 
Sample Added (ng/mL) Found (ng/mL) Recovery (%) 
1 1 1.02±0.03 102 
2 5 4.98±0.02 100.4 
3 10 9.96±0.09 100.4 
4 15 14.98±0.19 100.1 
5 20 20.02±0.45 99.9 
 
4 Conclusion 
A novel electrochemical immunosensor based on AuNPs/PGNR/GCE for the sensitive 
detection of HCC displayed a wide range of linear response (5-60 ng/ml) and a low detection 
limit (1 ng/mL). The immobilized anti-AFP molecules xhibited an excellent electrochemical 
response selective to the AFP in pH 7.4. The fabricted immunosensor exhibited high 
sensitivity, good repeatability, and long-term stability in quantitative detection of AFP. 
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• A novel porous graphene nanoribbon was obtained via chemical reduction method 
• AuNPs electrodeposited on porous graphene nanoribbon acts as platform for 
immobilizing biomolecule 
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